Stock COMPLETE GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Complete Genomics, Inc.

Equities

US20454K1043

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Complete Genomics, Inc.
2012 CNOOC Limited : U.S. sees "coordinated" foreign strategy to acquire U.S. technology RE

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Complete Genomics, Inc. : BGI-Shenzhen Completes Acquisition of Complete Genomics
13-03-18
 PR
Complete Genomics, Inc. : BGI-Shenzhen Successfully Completes Tender Offer For Complete Genomics, Inc.
13-03-15
 PR
Complete Genomics, Inc. : BGI-Shenzhen And Complete Genomics, Inc. Receive Approval From The State Administration Of Foreign Exchange Of The PRC For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
13-03-12
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
13-03-04
 PR
Complete Genomics, Inc. : BGI-Shenzhen And Complete Genomics, Inc. Receive Approval From The Ministry Of Commerce Of The PRC For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
13-02-25
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, inc.
13-02-22
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
13-02-06
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer for Complete Genomics, Inc.
13-02-01
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
13-01-25
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
13-01-18
 PR
Complete Genomics, Inc. : Bgi-Shenzhen And Complete Genomics, Inc. Receive Clearance From The National Development And Reform Commission Of The Prc For Bgi-Shenzhen'S Proposed Acquisition Of Complete Genomics, Inc.
13-01-14
 PU
Complete Genomics, Inc. : BGI-Shenzhen and Complete Genomics, Inc. Receive Clearance from the National Development and Reform Commission of the PRC for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
13-01-11
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer for Complete Genomics, Inc.
13-01-11
 PR
Complete Genomics, Inc. : BGI-Shenzhen And Complete Genomics, Inc. Receive Early Termination Of Hart-Scott-Rodino Waiting Period
13-01-07
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
13-01-07
 PR
Complete Genomics, Inc. : BGI-Shenzhen and Complete Genomics, Inc. Receive CFIUS Clearance for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
12-12-28
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer for Complete Genomics, Inc.
12-12-28
 PR
CNOOC Limited : U.S. sees "coordinated" foreign strategy to acquire U.S. technology
12-12-21
 RE
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
12-12-13
 PR
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
12-11-20
 PR
Complete Genomics, Inc. : Complete Genomics Reports Third Quarter 2012 Results
12-11-09
 PU
Complete Genomics, Inc. : BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
12-10-22
 PR
Complete Genomics, Inc. : Complete Genomics Announces Court's Favorable Ruling in Patent Litigation Against Illumina, Inc.
12-10-18
 PU
Complete Genomics, Inc. : BGI-Shenzhen Begins Tender Offer to Acquire Complete Genomics, inc.
12-09-25
 PR
Complete Genomics, Inc. : SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Complete Genomics, Inc. in Connection with the Sale of the Company to BGI-Shenzhen
12-09-19
 BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Complete Genomics, Inc.